SNSE logo
SNSE NASDAQ US

Sensei Biotherapeutics, Inc. - Common Stock

Healthcare · Biotechnology Website · IPO Feb 2021
$31.02
▼ $-3.77 (-10.84%)
Vol 61K
3
Quality Score
fail
Mkt Cap
$13.5M
ROE
-80.0%
D/E
0.84
Beta
0.32
52W
$5–$18

Wall Street Consensus

6 analysts · Apr 2026
0
Strong Buy
0
Buy
3
Hold
1
Sell
2
Strong Sell
0.0%
Buy Rating

Price Chart

Similar Stocks

ESLA
Estrella Immunopharma Inc
$58.9M
RLYB
Rallybio Corp
$29.0M
ALGS
Aligos Therapeutics Inc
$57.4M
ATRA
Atara Biotherapeutics Inc
P/E 5.6
$130.4M
LITS
Lite Strategy Inc
$48.6M
CELU
Celularity Inc
$31.6M
CRVO
CervoMed Inc
$73.1M
NXTC
NextCure Inc
$49.7M
RNXT
RenovoRx Inc
$30.8M

Earnings

Beat rate: 60.0%
Quarter EPS Est EPS Act Surprise
Dec 2025 $-4.91 $-3.74 +$1.17
Sep 2025 $-4.19 $-3.62 +$0.57
Jun 2025 $-5.71 $-3.91 +$1.80
Mar 2025 $-4.56 $-5.40 $-0.84

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -74.8% -74.8% -74.8% -74.8% -74.8% -80.0%
P/E (TTM) — — — — — —
Net Margin — — — — — —
Gross Margin — — — — — —
D/E Ratio 1.26 1.26 1.26 1.26 1.26 0.84
Current Ratio 7.64 7.64 7.64 7.64 7.64 5.81

Key Ratios

ROA (TTM)
-67.5%
P/B
0.3
EPS (TTM)
$-19.16
CF/Share
$-1.28
52W High
$18.35
52W Low
$5.00
$5.00 52-Week Range $18.35

How does SNSE compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

SNSE AAPG ABEO ABOS ABP

SNSE valuation vs Biotechnology peers

P/E ratio
—
▼ 0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼ 0% below peers (12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
0.3
▼ 87% below peers (2.5)
vs Peers
vs Industry
Undervalued
Div yield
—
▼ 0% below peers (0.0%)
vs Peers
vs Industry
Low yield

SNSE profitability vs Biotechnology peers

ROE
-80.0%
▼ 19% below peers (-67.3%)
vs Peers
vs Industry
Below avg
Net margin
—
▼ 0% below peers (-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼ 0% below peers (78.6%)
vs Peers
vs Industry
In line
ROA
-67.5%
▼ 45% below peers (-46.7%)
vs Peers
vs Industry
Weak

SNSE financial health vs Biotechnology peers

D/E ratio
0.8
▼ 0% below peers (0.0)
vs Peers
vs Industry
In line
Current ratio
5.8
▲ 31% above peers (4.4)
vs Peers
vs Industry
Below avg
Beta
0.3
▼ 67% below peers (1.0)
vs Peers
vs Industry
More volatile

SNSE fundamentals radar

SNSE Peer median Industry

SNSE profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

SNSE vs peers: key metrics

Latest News

No related news yet